ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 168 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,629,019 | +38.7% | 54,355 | -5.2% | 0.31% | +24.7% |
| Q3 2023 | $1,174,425 | +6.9% | 57,317 | +3.7% | 0.25% | +14.1% |
| Q2 2023 | $1,098,453 | +20.4% | 55,282 | +3.8% | 0.22% | -16.3% |
| Q1 2023 | $912,566 | -28.3% | 53,273 | -18.1% | 0.26% | -78.7% |
| Q4 2022 | $1,272,226 | +20.0% | 65,009 | -2.1% | 1.23% | +26.8% |
| Q3 2022 | $1,060,000 | +4.4% | 66,410 | -9.9% | 0.97% | +26.0% |
| Q2 2022 | $1,015,000 | -14.8% | 73,743 | -1.9% | 0.77% | +37.4% |
| Q1 2022 | $1,192,000 | -38.2% | 75,177 | -14.9% | 0.56% | -19.9% |
| Q4 2021 | $1,929,000 | – | 88,385 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |